Harvard Bioscience, Inc. (HBIO) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
84 OCTOBER HILL RD HOLLISTON, MA 01746 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3826 - Laboratory Analytical Instruments (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 4,508 | 7,821 | 8,317 | 8,335 | 8,173 | 5,733 | |||
| Cash and cash equivalents | 4,508 | 7,821 | 8,317 | 8,335 | 8,173 | 5,733 | |||
| Receivables | 16,705 | 21,834 | 17,766 | 20,704 | 21,463 | 16,236 | |||
| Inventory, net of allowances, customer advances and progress billings | 26,439 | 27,587 | 22,262 | 22,061 | 25,087 | 21,353 | |||
| Inventory | 26,439 | 27,587 | 22,262 | 22,061 | 25,087 | 21,353 | |||
| Other current assets | 3,472 | 4,341 | 3,355 | 2,472 | 3,109 | 4,213 | |||
| Total current assets: | 51,124 | 61,583 | 51,700 | 53,572 | 57,832 | 47,535 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 5,816 | 6,897 | 7,761 | 8,463 | ✕ | ✕ | |||
| Property, plant and equipment | 3,366 | 3,415 | 3,960 | 4,776 | 5,898 | 4,140 | |||
| Intangible assets, net (including goodwill) | 77,274 | 85,074 | 91,741 | 95,786 | 103,068 | 57,173 | |||
| Goodwill | 56,260 | 57,689 | 58,590 | 57,381 | 57,304 | 39,969 | |||
| Intangible assets, net (excluding goodwill) | 21,014 | 27,385 | 33,151 | 38,405 | 45,764 | 17,204 | |||
| Regulated entity, other noncurrent assets | (151) | ||||||||
| Other noncurrent assets | 7,780 | 5,375 | 1,092 | 2,273 | 1,604 | 324 | |||
| Other undisclosed noncurrent assets | 211 | 333 | |||||||
| Total noncurrent assets: | 94,236 | 100,761 | 104,554 | 111,298 | 110,781 | 61,819 | |||
| TOTAL ASSETS: | 145,360 | 162,344 | 156,254 | 164,870 | 168,613 | 109,354 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 6,447 | 4,911 | 5,972 | 5,948 | 14,099 | 10,342 | |||
| Taxes payable | ✕ | ✕ | 609 | 978 | 387 | ||||
| Accounts payable | 6,447 | 4,911 | 5,972 | 5,339 | 7,359 | 5,404 | |||
| Accrued liabilities | 5,762 | 4,551 | |||||||
| Deferred revenue | 3,370 | 4,266 | 3,771 | 3,949 | ✕ | ✕ | |||
| Debt | 4,091 | 3,515 | 2,000 | 2,424 | 4,399 | 2,765 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 633 | ||
| Other liabilities | 7,486 | 10,762 | 7,478 | 6,091 | 1,588 | 301 | |||
| Other undisclosed current liabilities | 1,855 | 1,862 | 1,832 | 6,900 | 1,420 | ||||
| Total current liabilities: | 23,249 | 25,316 | 21,053 | 25,312 | 21,506 | 14,041 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 43,013 | 51,583 | 53,767 | 55,141 | 58,796 | 8,983 | |||
| Long-term debt, excluding current maturities | 43,013 | 45,095 | 46,286 | 46,917 | 58,796 | 8,983 | |||
| Liabilities, other than long-term debt | 6,878 | 2,044 | 4,753 | 2,723 | 5,587 | 5,430 | |||
| Accounts payable and accrued liabilities | 3,286 | 1,466 | |||||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | 2,301 | 3,964 | ||
| Deferred income tax liabilities | 590 | 1,558 | 1,899 | 1,974 | ✕ | ✕ | |||
| Other liabilities | 1,006 | 486 | 2,854 | 749 | |||||
| Operating lease, liability | 5,282 | 6,488 | 7,481 | 8,224 | ✕ | ✕ | |||
| Total noncurrent liabilities: | 49,891 | 53,627 | 58,520 | 57,864 | 64,383 | 14,413 | |||
| Total liabilities: | 73,140 | 78,943 | 79,573 | 83,176 | 85,889 | 28,454 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 72,220 | 83,401 | 76,681 | 81,694 | 82,724 | 80,900 | |||
| Common stock | 454 | 452 | 444 | 438 | 436 | 419 | |||
| Additional paid in capital | 229,008 | 225,650 | 232,357 | 229,189 | 226,377 | 218,792 | |||
| Accumulated other comprehensive loss | (15,052) | (10,027) | (13,066) | (12,689) | (13,532) | (10,676) | |||
| Accumulated deficit | (142,190) | (132,674) | (132,386) | (124,576) | (119,889) | (116,967) | |||
| Other undisclosed equity, attributable to parent | (10,668) | (10,668) | (10,668) | (10,668) | |||||
| Total equity: | 72,220 | 83,401 | 76,681 | 81,694 | 82,724 | 80,900 | |||
| TOTAL LIABILITIES AND EQUITY: | 145,360 | 162,344 | 156,254 | 164,870 | 168,613 | 109,354 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 113,335 | 118,904 | 102,100 | 116,176 | 120,774 | 101,882 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (52,516) | (51,252) | (44,059) | (51,854) | (57,593) | (54,285) | ||
| Gross profit: | 60,819 | 67,652 | 58,041 | 64,322 | 63,181 | 47,597 | ||
| Operating expenses | (67,752) | (65,586) | (57,820) | (63,945) | (62,197) | (47,698) | ||
| Operating income (loss): | (6,933) | 2,066 | 221 | 377 | 984 | (101) | ||
| Nonoperating expense | (2,246) | (2,206) | (7,513) | (5,879) | (8,959) | (1,987) | ||
| Gain (loss), foreign currency transaction, before tax | 148 | (534) | ||||||
| Other nonoperating income (expense) | 302 | (666) | (806) | (469) | (3,740) | (740) | ||
| Interest and debt expense | (393) | (385) | (5,367) | (713) | ||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 393 | 385 | 5,367 | 713 | ||||
| Loss from continuing operations before income taxes: | (9,179) | (140) | (7,292) | (5,502) | (7,975) | (2,088) | ||
| Income tax expense (benefit) | (337) | (148) | (518) | 815 | 3,676 | 1,223 | ||
| Loss from continuing operations: | (9,516) | (288) | (7,810) | (4,687) | (4,299) | (865) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (288) | (7,810) | (4,687) | (2,922) | (865) | |
| Income from discontinued operations | 1,377 | |||||||
| Net loss available to common stockholders, diluted: | (9,516) | (288) | (7,810) | (4,687) | (2,922) | (865) | ||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (9,516) | (288) | (7,810) | (4,687) | (2,922) | (865) | ||
| Other comprehensive income (loss) | (5,025) | 3,039 | (377) | 843 | (2,856) | 5,982 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (14,541) | 2,751 | (8,187) | (3,844) | (5,778) | 5,117 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.